
Vincerx Pharma Inc
NASDAQ:VINC

Income Statement
Earnings Waterfall
Vincerx Pharma Inc
Revenue
|
0
USD
|
Operating Expenses
|
-31.5m
USD
|
Operating Income
|
-31.5m
USD
|
Other Expenses
|
1.4m
USD
|
Net Income
|
-30.1m
USD
|
Income Statement
Vincerx Pharma Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||
Operating Expenses |
(11)
|
(20)
|
(38)
|
(55)
|
(63)
|
(75)
|
(76)
|
(73)
|
(71)
|
(67)
|
(58)
|
(52)
|
(43)
|
(35)
|
(31)
|
(28)
|
(31)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(11)
|
(17)
|
(23)
|
(23)
|
(21)
|
(20)
|
(19)
|
(18)
|
(17)
|
(16)
|
(14)
|
(12)
|
(12)
|
(12)
|
(16)
|
|
Research & Development |
(7)
|
(5)
|
(16)
|
(28)
|
(40)
|
(51)
|
(54)
|
(53)
|
(52)
|
(47)
|
(41)
|
(37)
|
(29)
|
(23)
|
(19)
|
(16)
|
(15)
|
|
Other Operating Expenses |
0
|
(11)
|
(11)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(11)
N/A
|
(20)
-90%
|
(38)
-85%
|
(55)
-47%
|
(63)
-14%
|
(75)
-19%
|
(76)
-1%
|
(73)
+3%
|
(71)
+3%
|
(67)
+6%
|
(58)
+14%
|
(52)
+9%
|
(43)
+19%
|
(35)
+18%
|
(31)
+12%
|
(28)
+8%
|
(31)
-12%
|
|
Pre-Tax Income | ||||||||||||||||||
Interest Income Expense |
(6)
|
(3)
|
13
|
6
|
23
|
25
|
11
|
18
|
7
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(2)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
2
|
2
|
2
|
1
|
(4)
|
1
|
1
|
1
|
|
Pre-Tax Income |
(17)
N/A
|
(23)
-38%
|
(25)
-8%
|
(49)
-97%
|
(39)
+20%
|
(49)
-26%
|
(66)
-33%
|
(58)
+12%
|
(65)
-12%
|
(63)
+3%
|
(56)
+11%
|
(49)
+13%
|
(40)
+18%
|
(38)
+5%
|
(29)
+24%
|
(27)
+6%
|
(30)
-11%
|
|
Net Income | ||||||||||||||||||
Income from Continuing Operations |
(17)
|
(23)
|
(25)
|
(49)
|
(39)
|
(49)
|
(66)
|
(58)
|
(65)
|
(63)
|
(56)
|
(49)
|
(40)
|
(38)
|
(29)
|
(27)
|
(30)
|
|
Net Income (Common) |
(17)
N/A
|
(23)
-38%
|
(25)
-8%
|
(49)
-97%
|
(39)
+20%
|
(49)
-26%
|
(66)
-33%
|
(58)
+12%
|
(65)
-12%
|
(63)
+3%
|
(56)
+11%
|
(49)
+13%
|
(40)
+18%
|
(38)
+5%
|
(29)
+24%
|
(27)
+6%
|
(30)
-11%
|
|
EPS (Diluted) |
-3.16
N/A
|
-1.66
+47%
|
-1.51
+9%
|
-2.76
-83%
|
-2.29
+17%
|
-2.36
-3%
|
-3.13
-33%
|
-2.78
+11%
|
-3.11
-12%
|
-2.98
+4%
|
-2.65
+11%
|
-2.31
+13%
|
-37.72
-1 533%
|
-35.74
+5%
|
-15.07
+58%
|
-11.83
+21%
|
-15.85
-34%
|